Health

Osage University Partners has backed the immunotherapy developer in a series B round, which took its overall funding to over $335m.

Alphabet, Eli Lilly, Dong-A ST and Alexandria Real Estate Equities backed the immunotherapy developer in a series B round, which took its overall funding to over $335m.

China Merchants Capital has co-led a series B round sized at almost $99.2m that also attracted existing shareholder Legend Capital.

MIT spinout Iterative Scopes has now raised $43.5m altogether from investors including Eli Lilly and Johnson & Johnson.

Pulse Medical and BioMap are among the companies that raised nine-figure rounds, while Amwell bought two corporate-backed companies at once.

The Tencent-backed owner of pharmaceutical platform Miaoshou Doctor has raised a series F round from new and returning investors, six months after it completed a series E.

The multi-corporate-backed biologic pill developer has listed on the Nasdaq Global Market, pricing the shares below their range.

Pulse Medical and BioMap are among the companies that raised nine-figure rounds, while Amwell bought two corporate-backed companies at once.

Intervenn Biosciences was co-founded by faculty members at Stanford University and University of California, Berkeley.

SoftBank and Heritage Provider Network were among the investors who co-led a series C round for Intervenn Biosciences, which is developing precision medicine.

The MDC spinout raised a series B round which will be used to boost its manufacturing capacity and advance its pipeline of candidates.